AHA Scientific Sessions 2018 Highlights

Highlights from ACC.17 scientific sessions

Highlights from ACC 15 Scientific Sessions: Part 2

No: 906-12. March 15, 2015, 10:45–12:15pm. San Diego, CA. Kaymaz and Tokgözoğlu. Highlights from ACC 15 Scientific Sessions: Part 2 Anatol J Cardiol 2015; 15: 596-600 600

Highlights from ACC 15 Scientific Sessions: Part 1

Meeting highlights : highlights of the 49th scientific sessions of the american college of cardiology

Acute Coronary Syndromes The Trial: SYMPHONY II Presenter: Kristin Newby, Duke University Medical Center, Durham, NC. The study: A randomized trial of sibrafiban (an oral glycoprotein [GP] IIb/IIIa antagonist) in patients with acute coronary syndromes. The study was originally designed to include 8400 patients, but it was terminated prematurely by the sponsor (unilaterally) after the negative r...

Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.

Unstable Angina The Trial: FRISC II Presenters: Lars Wallentin and Bo Lagerqvist, Cardiothoracic Centre, University Hospital, Uppsala, Sweden. The study: A randomized, placebo-controlled trial of lowmolecular-weight heparin (dalteparin) in conjunction with either early revascularization or conservative medical therapy in 2457 patients with unstable angina or non–Q-wave myocardial infarction (MI...